Tata Chemicals Ltd Share Price – NSE /  BSE

Chemicals, Small Cap

Tata Chemicals will hold a meeting of the Board of Directors of the Company on 4 May 2026.

The rally comes amid rising market speculation that a public listing of Tata Sons could unlock value for group companies. Tata Chemicals holds 10,237 securities in Tata Sons, adding to optimism around potential upside for shareholders.

The development has brought regulatory requirements back into focus. Tata Sons is currently classified as an upper-layer NBFC, which mandates listing under existing norms. However, evolving regulatory guidelines have created uncertainty around the timeline.

Tata Chemicals is a leading supplier of choice to glass, detergent, industrial and chemical sectors. The company has a strong position in the crop protection business through its subsidiary company, Rallis India.

On a consolidated basis, Tata Chemicals reported net loss of Rs 93 crore in Q3 December 2025 as against net loss of Rs 53 crore in Q3 December 2024. Net sales declined 1.11% YoY to Rs 3550 crore in Q3 December 2025.

Tata Chemicals announced that in order to rationalise the number of intermediate entities in the holding structure of the Company's UK operations, Gusiute Holdings (UK) (GHUL) has transferred all its assets and investments to Homefield UK (HFUK) effective 30 March 2026.

Consequent to this transfer, GHUL has ceased to be a material subsidiary of the Company and HFUK is considered as a material subsidiary of the Company.

Powered by Capital Market - Live News

Tata Chemicals has announced an investment of Rs 515 crore to set up a new greenfield manufacturing facility in Tamil Nadu as part of its capacity expansion and supply chain strengthening strategy. The new facility will be located at Valinokkam in the Ramanathapuram district of Tamil Nadu and will be used for the production of Iodised Vacuum Salt Dried (IVSD). The plant will have an installed capacity of 210 Kilo Tonnes Per Annum (KTPA). Tata Chemicals is expected to complete the project within 36 months and will fund the investment through internal accruals and or external financing.

Currently, Tata Chemicals has an IVSD manufacturing capacity of 1.6 million tonnes per annum at its Mithapur plant in Gujarat. The new greenfield facility in South India is intended to create a second major manufacturing site for IVSD, helping the company diversify its production base and improve regional supply capabilities.

The strategic rationale for the investment includes enhancing supply chain efficiency and optimizing logistics costs by bringing production closer to key southern markets. The new facility is expected to support better distribution, reduce transit time, and improve overall operational efficiency for the company's salt business.

Powered by Capital Market - Live News